DBV Technologies Half-Yearly Liquidity Statement

DBV Technologies has published its half-yearly liquidity contract report with ODDO BHF. As of December 31, 2024, the liquidity account included 266,868 DBV Technologies shares and 106,930.51 euros. When the contract was set up in July 2018, these figures were 41,159 shares and 432,367.25 euros respectively.

During the second half of 2024, 1,682 transactions were made for purchase and 1,800 for sale. The volumes traded consisted of 404,081 shares and 296,390.97 euros for purchase, as well as 440,957 shares and 340,906.76 euros for sale.

DBV Technologies is listed on Euronext Paris and Nasdaq. This French biopharmaceutical laboratory focuses on the treatment of food allergies thanks to its VIASKIN® technology.